Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $101.4M | 22 | 99.2% |
| Consulting Fee | $579,843 | 24 | 0.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,253 | 2 | 0.2% |
| Travel and Lodging | $38,504 | 8 | 0.0% |
| Food and Beverage | $1,406 | 28 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $101.4M | 22 | $0 (2023) |
| Gilead Sciences, Inc. | $461,877 | 34 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $228,003 | 11 | $0 (2024) |
| Amicus Therapeutics, Inc. | $139,060 | 16 | $0 (2020) |
| Ultragenyx Pharmaceutical Inc. | $65.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $689,946 | 46 | Gilead Sciences, Inc. ($461,877) |
| 2023 | $2.5M | 6 | PFIZER INC. ($2.5M) |
| 2022 | $98.9M | 16 | PFIZER INC. ($98.9M) |
| 2020 | $51,616 | 8 | Amicus Therapeutics, Inc. ($51,616) |
| 2019 | $87,444 | 8 | Amicus Therapeutics, Inc. ($87,444) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $282,153.00 | General |
| 12/14/2023 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $102,821.00 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $39,477,783.00 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $23,721,550.00 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $5,966,231.50 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $4,978,374.50 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $4,561,816.70 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $4,368,108.00 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $3,234,775.50 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $3,181,040.66 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $2,908,700.00 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $2,496,071.50 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $1,840,252.50 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $1,070,874.70 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $770,625.00 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $293,816.44 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $14,925.30 | General |
| 10/05/2022 | PFIZER INC. | — | Acquisitions | Cash or cash equivalent | $12,212.76 | General |
| 10/06/2020 | Amicus Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,623.64 | General |
| 06/30/2020 | Amicus Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,625.00 | General |
| 06/02/2020 | Amicus Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $2,947.61 | General |
| 03/24/2020 | Amicus Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,625.00 | General |
| 03/24/2020 | Amicus Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $7,750.00 | General |
| 03/12/2020 | Amicus Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $2,871.06 | General |
| 02/25/2020 | Amicus Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $84.35 | General |
About Dr. Ted Love, M.D
Dr. Ted Love, M.D is a Cardiovascular Disease healthcare provider based in Hillsborough, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1417299728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ted Love, M.D has received a total of $102.2M in payments from pharmaceutical and medical device companies, with $689,946 received in 2024. These payments were reported across 84 transactions from 5 companies. The most common payment nature is "Acquisitions" ($101.4M).
Practice Information
- Specialty Cardiovascular Disease
- Location Hillsborough, CA
- Active Since 03/25/2013
- Last Updated 03/25/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417299728
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.